Pretreatment Hematocrit as an Independent Prognostic Variable in Hodgkin’s Disease

Pretreatment hematocrit in 117 advanced-stage Hodgkin's disease patients treated with a combined modality therapy program was evaluated as an independent prognostic variable with regard to survival and relapse-free survival. Age greater than 40 years, and multiple extranodal sites of involvemen...

Full description

Saved in:
Bibliographic Details
Published in:Blood 1986-08, Vol.68 (2), p.562-564
Main Authors: Jaffe, Howard S., Cadman, Edwin C., Farber, Lenard R., Bertino, Joseph R.
Format: Article
Language:English
Subjects:
Adult
Biological and medical sciences
Hematocrit
Hematologic and hematopoietic diseases
Hodgkin Disease - diagnosis
Hodgkin Disease - pathology
Humans
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
Middle Aged
Prognosis
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pretreatment hematocrit in 117 advanced-stage Hodgkin's disease patients treated with a combined modality therapy program was evaluated as an independent prognostic variable with regard to survival and relapse-free survival. Age greater than 40 years, and multiple extranodal sites of involvement were found to be statistically significant independent negative prognostic factors with regard to survival. Pretreatment hematocrit, however, was not an independent negative prognostic variable.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.V68.2.562.562